Entrez Id: |
140805 |
Gene Symbol: |
HT |
HT
|
|
Hashimoto thyroiditis
|
|
170
|
0.505 |
0.731 |
|
0.070 |
None
|
0.857 |
7
|
0
|
2002 |
2019 |
Entrez Id: |
246319 |
Gene Symbol: |
VAMAS6 |
VAMAS6
|
|
Vitiligo
|
|
23
|
0.729 |
0.269 |
|
0.040 |
None
|
1.000 |
4
|
0
|
2005 |
2020 |
TRBV20OR9-2
|
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
456
|
0.403 |
0.923 |
|
0.040 |
None
|
1.000 |
4
|
0
|
2010 |
2014 |
TSBP1-AS1
|
|
TSBP1 and BTNL2 antisense RNA 1
|
|
63
|
0.638 |
0.692 |
|
0.100 |
None
|
1.000 |
3
|
3
|
2010 |
2012 |
Entrez Id: |
4513 |
Gene Symbol: |
COX2 |
COX2
|
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
875
|
0.352 |
0.962 |
|
0.030 |
None
|
1.000 |
3
|
0
|
2009 |
2019 |
Entrez Id: |
28 |
Gene Symbol: |
ABO |
ABO
|
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
443
|
0.427 |
0.885 |
|
0.020 |
None
|
< 0.001 |
2
|
0
|
1977 |
1980 |
HLA-DRB4
|
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
87
|
0.565 |
0.846 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2001 |
2006 |
HLA-DRB9
|
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
33
|
0.682 |
0.654 |
|
0.100 |
None
|
1.000 |
2
|
2
|
2010 |
2019 |
Entrez Id: |
3439 |
Gene Symbol: |
IFNA1 |
IFNA1
|
P01562
|
interferon alpha 1
|
|
662
|
0.371 |
0.923 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2014 |
2017 |
Entrez Id: |
3447 |
Gene Symbol: |
IFNA13 |
IFNA13
|
P01562
|
interferon alpha 13
|
|
646
|
0.374 |
0.923 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2014 |
2017 |
Entrez Id: |
373071 |
Gene Symbol: |
AIS1 |
AIS1
|
|
autoimmune susceptibility 1
|
|
5
|
0.861 |
0.115 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2002 |
2003 |
MIR196A2
|
|
microRNA 196a-2
|
|
70
|
0.599 |
0.577 |
|
0.020 |
None
|
1.000 |
2
|
1
|
2013 |
2015 |
Entrez Id: |
406993 |
Gene Symbol: |
MIR211 |
MIR211
|
|
microRNA 211
|
|
106
|
0.552 |
0.577 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2017 |
2017 |
Entrez Id: |
100129192 |
Gene Symbol: |
MICC |
MICC
|
|
MHC class I polypeptide-related sequence C (pseudogene)
|
|
3
|
0.890 |
0.154 |
|
0.100 |
None
|
1.000 |
1
|
3
|
2010 |
2010 |
Entrez Id: |
100500888 |
Gene Symbol: |
MIR3940 |
MIR3940
|
|
microRNA 3940
|
|
6
|
0.861 |
0.154 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2016 |
2016 |
ATP6V1G2-DDX39B
|
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
15
|
0.769 |
0.423 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2010 |
2010 |
PPT2-EGFL8
|
|
PPT2-EGFL8 readthrough (NMD candidate)
|
|
17
|
0.792 |
0.462 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2010 |
2010 |
LINC01149
|
|
long intergenic non-protein coding RNA 1149
|
|
13
|
0.792 |
0.346 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2010 |
2010 |
Entrez Id: |
10255 |
Gene Symbol: |
HCG9 |
HCG9
|
|
HLA complex group 9
|
|
22
|
0.700 |
0.500 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2010 |
2010 |
Entrez Id: |
102724552 |
Gene Symbol: |
RERE-AS1 |
RERE-AS1
|
|
RERE antisense RNA 1
|
|
9
|
0.890 |
0.077 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
LINC02210-CRHR1
|
P34998
|
LINC02210-CRHR1 readthrough
|
|
123
|
0.570 |
0.692 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2016 |
2016 |
LINC02356
|
|
long intergenic non-protein coding RNA 2356
|
|
7
|
0.931 |
0.115 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
LINC02570
|
|
long intergenic non-protein coding RNA 2570
|
|
2
|
0.931 |
0.115 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2010 |
2010 |
LINC02571
|
|
long intergenic non-protein coding RNA 2571
|
|
28
|
0.743 |
0.500 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2010 |
2010 |
Entrez Id: |
107075310 |
Gene Symbol: |
MTCO2P12 |
MTCO2P12
|
|
MT-CO2 pseudogene 12
|
|
703
|
0.368 |
0.962 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2011 |
2011 |